# Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment

> **NCT02034669** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tri Phuoc Biotechnology., JSC** · enrollment: 48 (estimated)

## Conditions studied

- Acute Spinal Cord Injury

## Interventions

- **DEVICE:** Laminectomy
- **DEVICE:** Intradural space
- **DEVICE:** Intrathecal
- **DEVICE:** Intravenous

## Key facts

- **NCT ID:** NCT02034669
- **Lead sponsor:** Tri Phuoc Biotechnology., JSC
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2014-12
- **Final completion:** 2015-03
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2014-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02034669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02034669, "Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02034669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*